Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R I Parker

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Hematology/Oncology Clinics of North America|July 26, 2000
Hematologic aspects of systemic mastocytosisR I Parker
Journal of Learning Disabilities|August 1, 1993
Comments on Ellis's integrative strategy instruction modelR I Parker
The Journal of Investigative Dermatology|March 1, 1991
Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell diseaseR I Parker
The Journal of Investigative Dermatology|March 1, 1991
Hematologic aspects of mastocytosis: II: Management of hematologic disorders in association with systemic mast cell diseaseR I Parker
Critical Care Medicine|June 8, 2001
IIb/IIIa or not IIb/IIIa, that is adhesionR I Parker
Critical Care Medicine|March 1, 1994
Aggressive non-blood product support of Jehovah's WitnessesR I Parker
Critical Care Clinics|July 1, 1997
Etiology and treatment of acquired coagulopathies in the critically ill adult and childR I Parker
The Journal of Investigative Dermatology|March 1, 1991
Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell diseaseR I Parker
The Journal of Investigative Dermatology|March 1, 1991
Hematologic aspects of mastocytosis: II: management of hematologic disorders in association with systemic mast cell diseaseR I Parker
Blood|November 1, 1987
Fibrin monomer induces binding of endogenous platelet von Willebrand factor to the glycocalicin portion of platelet glycoprotein IBR I Parker, H R Gralnick
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Hematology/Oncology Clinics of North America|July 26, 2000
Hematologic aspects of systemic mastocytosisR I Parker
Journal of Learning Disabilities|August 1, 1993
Comments on Ellis's integrative strategy instruction modelR I Parker
The Journal of Investigative Dermatology|March 1, 1991
Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell diseaseR I Parker
The Journal of Investigative Dermatology|March 1, 1991
Hematologic aspects of mastocytosis: II: Management of hematologic disorders in association with systemic mast cell diseaseR I Parker
Critical Care Medicine|June 8, 2001
IIb/IIIa or not IIb/IIIa, that is adhesionR I Parker
Critical Care Medicine|March 1, 1994
Aggressive non-blood product support of Jehovah's WitnessesR I Parker
Critical Care Clinics|July 1, 1997
Etiology and treatment of acquired coagulopathies in the critically ill adult and childR I Parker
The Journal of Investigative Dermatology|March 1, 1991
Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell diseaseR I Parker
The Journal of Investigative Dermatology|March 1, 1991
Hematologic aspects of mastocytosis: II: management of hematologic disorders in association with systemic mast cell diseaseR I Parker
Blood|November 1, 1987
Fibrin monomer induces binding of endogenous platelet von Willebrand factor to the glycocalicin portion of platelet glycoprotein IBR I Parker, H R Gralnick
Pageof 5